Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study
Per Soelberg Sørensen(University of Copenhagen), Melinda Magyari(University of Copenhagen), Caroline Ellinore Pihl(Copenhagen University Hospital), Rikke Ratzer(University of Copenhagen), Peter Vestergaard Rasmussen(Aarhus University Hospital), Luigi Pontieri(Rigshospitalet), Jakob Schäfer(Aalborg University Hospital), Alex Heick(Copenhagen University Hospital), Hanna Joensen(Rigshospitalet), Finn Sellebjerg(Danish Multiple Sclerosis Center)
Cited by 42
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293